The company opened its new global headquarters in Japan.
Takeda Pharmaceutical announced the opening of its new headquarters in Nihonbashi, Tokyo on July 2, 2018. The building was completed in March 2018.
The company announced that it agreed to sell its previous Tokyo headquarters as well as its Shin-Edobashi building to Takashimaya Company in December 2017 for 49.5 yen (approximately US$447 million).
Source: Takeda Pharmaceutical
Kyron.bio Raises €5.5M to Advance Precision Glycan Engineering for Safer Antibody Therapeutics
May 28th 2025Funding will support the company’s efforts to refine its proprietary glycan-engineering platform, expand its scientific and operational team, and advance preclinical studies of its engineered biologics.